CSI Market
Sign In | Register

Yew Bio pharm Group Inc (YEWB) Annual Income Statement

Annual · GAAP · USD millions
Access YEWB quarterly income statements →
By examining income statement figures across successive periods, users can identify shifts in Yew Bio pharm Group Inc's profitability and expense structure.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2020)
2020 		(Dec 31 2019) (Dec 31 2018) (Dec 31 2017) (Dec 31 2016)
Revenues
Revenue from Related Parties26.42
Sales Revenue, Goods, Gross27.31
Total Revenue27.31
Costs & Expenses
Cost of Goods and Services Sold23.78
Gross Profit3.53
Selling, Administration, Marketing0.99
Other Operating Expense / -Income-0.03
Total operating costs including COS24.74
Operating income / -loss2.57
Interest Expense0.00
Interest Expense, Other0.48
Net Interest Expense / -Income0.48
Other Nonoperating Gains (Losses)0.00
Foreign Currency Transaction Gain (Loss), Unrealized0.61
Other loss / -income-0.02
Total costs & expenses25.81
Income & Taxes
Income / -loss before income taxes1.49
Income taxes expenses / -benefit0.03
Income after income taxes1.46
Net income / -loss of other equity0.00
Income / -loss from continuing operations1.46
Net income / -loss1.46
Income / -loss to shareholder1.46
EBIT1.98
EBITD2.03
EBITDA3.26
Earnings Per Share
Basic EPS (excl. extra items)0.03
Extraordinary items0.01
Basic Net EPS0.04
Basic shares outstanding (Mill. of Units)51.70
Diluted Net EPS0.04
Diluted average shares (Mill. of Units)51.70
4 historic quarters locked

Sign in to unlock the full Yew Bio pharm Group Inc income statement history.

Sign In Create Free Account

About YEWB Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-K filings
  • Filed with the SEC: n/a

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.